Madrigal Pharmaceuticals Announces Proposed Public Offering Of Common Stock
December 18, 2017 at 13:08 PM EST
Madrigal Pharmaceuticals, Inc., today announced that it has commenced an underwritten public offering of $100 million of its common stock.
